Belief-Space Control for Personalized Cancer Treatment via Active Inference

Researchers develop a belief-space control framework using active inference to optimize personalized cancer treatment as a sequential decision-making problem with incomplete information. The approach integrates goal-directed treatment control with strategic information gathering under realistic medical measurement constraints, validated using clinical data from the AACR Project GENIE dataset.

This research advances computational approaches to oncology by reframing cancer treatment optimization as a belief-space planning problem rather than traditional reinforcement learning. The distinction matters fundamentally: cancer treatments don't merely navigate existing patient states but permanently alter the underlying dynamics governing how disease progresses, requiring adaptive frameworks that account for evolving system behavior alongside incomplete observability of patient conditions.

The active inference methodology provides a principled way to balance two competing objectives in clinical practice. Clinicians must both treat patients effectively toward remission while gathering diagnostic information to refine understanding of individual tumor characteristics and treatment responses. By unifying these goals through expected free-energy minimization, the framework respects real-world constraints where excessive testing burdens patients financially and physically while insufficient measurement leaves critical uncertainties unresolved.

Validation on actual AACR GENIE clinical data demonstrates practical viability beyond theoretical elegance. The ability to simultaneously perform patient categorization while maintaining high treatment efficacy suggests the approach captures clinically relevant heterogeneity that generic treatment protocols miss. This addresses a persistent challenge in precision medicine: current clinical workflows often segregate diagnostic and therapeutic decisions rather than optimizing them jointly.

The framework's implications extend beyond individual treatment planning. If sufficiently developed, such systems could improve clinical trial design, reduce healthcare costs by optimizing measurement strategies, and accelerate learning from real-world patient populations. The integration of explicit budget constraints acknowledges resource limitations that purely theoretical approaches often ignore, increasing translational potential. Future work addressing scalability to larger patient cohorts and integration with existing electronic health record systems will determine clinical adoption.

• →Active inference framework unifies treatment optimization and diagnostic information gathering under measurement budget constraints
• →Cancer treatment dynamics permanently shift during therapy, requiring belief-space planning rather than standard reinforcement learning
• →Clinical validation demonstrates simultaneous patient stratification and high treatment efficacy on real oncology data
• →Joint optimization of therapy and diagnostics addresses precision medicine's challenge of balancing treatment effectiveness with uncertainty reduction
• →Framework incorporates practical clinical constraints often ignored by theoretical medical AI approaches